Arkolith/Insider Trading/AGIO/Form 4

Viswanadhan Krishnan

Chief Corp Dev & StrategyAGIOS PHARMACEUTICALS, INC. (AGIO) · full profile →Form 4 · filed Mar 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$82K
Net Open-Market Flow
-$82K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Sell(S)3K$27.80$82K5K
Mar 5, 2026Option exercise(M)8K—$08K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 5, 2026Option exercise(M)8K—$016K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001439222-26-000049) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML